- October 6, 2021
2:00 PM - 3:00 PM ET
- Organized By:
Sponsored by the U.S. Food & Drug Administration (FDA)
Loriana Hernandez, Cancer Survivor |Patient Advocate | Emmy Award Winning Journalist & Speaker
Frank J. Penedo, PhD, Sylvester Professor of Psychology and Medicine, Center Associate Director for Cancer Survivorship & Translational Behavioral Sciences
Michelle Veras, MPH, Projects Director for the National LGBT Cancer Network
Karen Winkfield MD, PhD, Executive Director, Meharry-Vanderbilt Alliance
Rea Blakey - Associate Director for External Outreach and Engagement, Oncology Center of Excellence, FDA
Richard Pazdur, MD - Center Director, Oncology Center of Excellence, FDA
Registration required to attend: https://fdaoce.formstack.com/forms/ocecoca100621
The October 6, 2021 “Conversation On Cancer” (2pm – 3:00 pm ET) will address countless disparities faced by patients living with cancer in the Latinx LGBTQ+ community. Research indicates a plethora of issues faced by this community may contribute to higher incidences of some cancer types, higher mortality, and lower satisfaction among cancer survivors. A dynamic panel of patients, oncologists, and researchers will discuss the gaps and bridges to greater cancer equity by addressing the need for diversity, and inclusion surrounding sexual orientation and gender identity within the US Latinx community. This public panel discussion is in recognition of LBGTQ History Month and National Hispanic American Heritage Month. The archived recording will provide Spanish language captioning.
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov